There is growing evidence supporting a tumor‐suppressor role for Notch‐1 signaling in neuroendocrine tumors,15 and DLL3 is considered to promote neuroendocrine tumorigenesis by inhibiting the Notch receptor pathway.16 Here, DLL3 is linked to neoplasm.